DK1080192T3 - Antisense-oligonucleotider til behandling af prolifererende celler - Google Patents

Antisense-oligonucleotider til behandling af prolifererende celler

Info

Publication number
DK1080192T3
DK1080192T3 DK99926337T DK99926337T DK1080192T3 DK 1080192 T3 DK1080192 T3 DK 1080192T3 DK 99926337 T DK99926337 T DK 99926337T DK 99926337 T DK99926337 T DK 99926337T DK 1080192 T3 DK1080192 T3 DK 1080192T3
Authority
DK
Denmark
Prior art keywords
treatment
antisense oligonucleotides
proliferating cells
oligodesoxyribonucleotides
oligoribo
Prior art date
Application number
DK99926337T
Other languages
English (en)
Inventor
Andreas Boehle
Hans-Dieter Flad
Johannes Gerdes
Irina Aehrchen-Deinert
Original Assignee
Faustus Forschungs Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faustus Forschungs Cie filed Critical Faustus Forschungs Cie
Application granted granted Critical
Publication of DK1080192T3 publication Critical patent/DK1080192T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99926337T 1998-05-22 1999-05-20 Antisense-oligonucleotider til behandling af prolifererende celler DK1080192T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19822954A DE19822954A1 (de) 1998-05-22 1998-05-22 Antisense-Oligonukleotide zur Behandlung von proliferierenden Zellen
EP99926337A EP1080192B1 (de) 1998-05-22 1999-05-20 Antisense-oligonukleotide zur behandlung von proliferierenden zellen

Publications (1)

Publication Number Publication Date
DK1080192T3 true DK1080192T3 (da) 2004-11-29

Family

ID=7868624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99926337T DK1080192T3 (da) 1998-05-22 1999-05-20 Antisense-oligonucleotider til behandling af prolifererende celler

Country Status (8)

Country Link
EP (1) EP1080192B1 (da)
AT (1) ATE272112T1 (da)
AU (1) AU4363699A (da)
DE (2) DE19822954A1 (da)
DK (1) DK1080192T3 (da)
ES (1) ES2226393T3 (da)
PT (1) PT1080192E (da)
WO (1) WO1999061607A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19955576B4 (de) 1999-11-18 2008-02-28 Faustus Forschungs Cie. Translational Cancer Research Gmbh Transferverbindungen, ihre Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
ES2226393T3 (es) 2005-03-16
DE19822954A1 (de) 1999-11-25
AU4363699A (en) 1999-12-13
EP1080192A2 (de) 2001-03-07
EP1080192B1 (de) 2004-07-28
DE59910072D1 (de) 2004-09-02
WO1999061607A3 (de) 2000-03-23
WO1999061607A2 (de) 1999-12-02
ATE272112T1 (de) 2004-08-15
PT1080192E (pt) 2004-11-30

Similar Documents

Publication Publication Date Title
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
BR0016681B1 (pt) composição amaciante de tecidos, e, método de tratamento de tecido.
FI964792A0 (fi) raf-geenin ilmentymisen muuttaminen antisense-oligonukleotideillä
DK0986382T3 (da) RAF-kinasehæmmere
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
DK1117672T3 (da) Antisense-modulation af survivin-ekpression
ATE364386T1 (de) (s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom
DE69819167D1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
PL356698A1 (en) Inhibiting gene expression with dsrna
ATE486955T1 (de) Chimäre antisense oligonukleotide
DK1351744T3 (da) Anvendelse af specifikke ErbB4-antagonister til behandling af stenose
DK1112097T3 (da) Ny fremgangsmåde til fremstilling af substanser til overflademodificering
DE69813898D1 (de) Substituierte porphyrinen
DK1207904T3 (da) Nye kliniske parametre til bestemmelse af hæmatologisk toksicitet forud for radioimmunterapi
DK0954334T3 (da) Anvendelse af makrofag migration inhibitorisk faktor antagonister til anti-cancer terapi
DK1218494T3 (da) Præparater og fremgangsmåder til inhibering af C2-cellecyklusstandsning og sensibilisering af celler til DNA-beskadigende midler
DK1080192T3 (da) Antisense-oligonucleotider til behandling af prolifererende celler
BRPI0308119A2 (pt) microorganismo como portadores de seqüências de nucleotídeos codificando para antígenos de células para o tratamento de tumores.
EP1234877A4 (en) CELL PROLIFERATION INHIBITOR PROTEIN, POLYNUCLEOTIDE, ANTISENSE POLYNUCLEOTIDE POLYNUCLEOTIDE, CELL PROLIFERATION INHIBITORS, CANCER DIAGNOSTICS, CANCER REMEDIES AND GENE THERAPY COMPOSITION USING THE SAME
PT1153015E (pt) Pirimidina-2,4,6-trionas uteis como inibidores de metaloproteinases matriciais
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
UA94231C2 (ru) Олигонуклеотиды или их функциональные гомологи, композиция, которая содержит их, и способ лечения в-клеточной опухоли
ATE383422T1 (de) Hemmung des wachstums der chronischen myelogenen leukämischen zellen durch antisens- oligonukleotide die an crkl zielgerichtet sind
BRPI0517387A (pt) oligonucleotìdeos anti-senso para o tratamento de alergia e proliferação de células neoplásicas